Cristina Oprean

13PUBLICATIONS
19CO-AUTHORS
Haematological tumoursSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 13, 2026
Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.

|Mar 27, 2026
Giant Malignant Phyllodes Tumor with Secondary Thyroid Involvement.

Daciana Grujic, Teodora Hoinoiu, Catalin-Alexandru Pirvu

|Feb 26, 2026
Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Mircea Dragoș Median, Nicoleta Zenovia Antone, Simona Volovăț

|Jan 10, 2026
The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.

Larisa Maria Badau, Cristina Marinela Oprean, Andrei Dorin Ciocoiu

|Nov 27, 2025
Recurrence Patterns in Breast Cancer: A Single-Center Retrospective Analysis.

Cristina Marinela Oprean, Teodora Hoinoiu, Larisa Maria Badau

|May 14, 2025
Real-World, National Study of Palbociclib in HR+/HER2- Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021.

Cristina Marinela Oprean, Larisa Maria Badau, Ramona Petrita

Pageof 3

Frequent Collaborators

6 joint publications

Teodora Hoinoiu

6 joint publications

Larisa Maria Badau

2 joint publications

Radu Vidra

2 joint publications

Mircea Dragos Median